About-cancer/treatment/drugs/darbepoetinalfa/zh

達比泊汀·阿爾法（Darbepoetin Alfa）

本頁包含有關darbepoetin alfa的簡要信息，以及一些鏈接，這些鏈接指向有關該藥物的用途，研究結果和正在進行的臨床試驗的更多信息。

美國品牌名稱

Aranesp

FDA 批准

是

該藥物的FDA標籤信息可從DailyMed獲得。

用於癌症

Darbepoetin alfa被批准用於治療：

• 貧血 由骨髓抑制性化療引起的，用於某些類型的癌症。

有關Darbepoetin Alfa的更多信息

NCI藥物詞典中的定義-該藥物的詳細科學定義和其他名稱。

MedlinePlus關於Albebepoetin的信息-有關此藥物重要信息的通俗易懂的語言摘要，可能包括以下內容：

• 關於這種藥物的警告，

• 這種藥物的用途和用法，

• 在使用這種藥物之前，您應該告訴醫生什麼，

• 在使用該藥物之前，您應該了解些什麼，

• other drugs that may interact with this drug, and

• possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Clinical Trials Accepting Patients

Find Clinical Trials for Darbepoetin Alfa - Check for trials from NCI's list of cancer clinical trials now accepting patients.

Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.